We are live on ! Find out more
GLG Partners

GLG Partners Portfolio holdings

AUM $2.14B Turnover 59.22%
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PCTI
351
DELISTED
PCTEL
PCTI
$103K ﹤0.01%
+13,927
New +$98.3K
2017 Q4
0 quarters
MNDT
352
DELISTED
Mandiant
MNDT
$99K ﹤0.01%
7,000
-14,000
-67% -$213K
2017 Q2
2 quarters
LLL
353
DELISTED
L3 Technologies
LLL
$99K ﹤0.01%
500
– –
2015 Q4
8 quarters
WU icon
354
Western Union
WU
$2.11B
$98K ﹤0.01%
+5,145
New +$101K
2017 Q4
0 quarters
NAGE icon
355
Niagen Bioscience
NAGE
$163M
$97K ﹤0.01%
+16,473
New +$89K
2017 Q4
0 quarters
LGC.U
356
DELISTED
Legacy Acquisition Corp Units
LGC.U
$95K ﹤0.01%
+9,547
New +$95.3K
2017 Q4
0 quarters
RTN
357
DELISTED
Raytheon
RTN
$94K ﹤0.01%
500
– –
2017 Q1
3 quarters
HOLX icon
358
DELISTED
Hologic
HOLX
$91K ﹤0.01%
+2,131
New +$85K
2017 Q4
0 quarters
SNA icon
359
Snap-on
SNA
$18.8B
$87K ﹤0.01%
+499
New +$80.7K
2017 Q4
0 quarters
LITE icon
360
Lumentum
LITE
$49.5B
$83K ﹤0.01%
1,700
– –
2017 Q3
1 quarter
CXRX
361
DELISTED
Concordia International
CXRX
$80K ﹤0.01%
122,016
-1,370
-1% -$943
2016 Q2
6 quarters
FLR icon
362
Fluor
FLR
$6.17B
$79K ﹤0.01%
+1,529
New +$71.2K
2017 Q4
0 quarters
AGN
363
DELISTED
Allergan plc
AGN
$79K ﹤0.01%
+486
New +$87.2K
2017 Q4
0 quarters
AZTA icon
364
Azenta
AZTA
$1.9B
$78K ﹤0.01%
+3,251
New +$92.3K
2017 Q4
0 quarters
SRE icon
365
Sempra
SRE
$52B
$76K ﹤0.01%
+1,414
New +$82K
2017 Q4
0 quarters
MCHX icon
366
Marchex
MCHX
$63.9M
$75K ﹤0.01%
+23,072
New +$73.7K
2017 Q4
0 quarters
LLY icon
367
Eli Lilly
LLY
$1.31T
$74K ﹤0.01%
+880
New +$74.9K
2017 Q4
0 quarters
HCA icon
368
HCA Healthcare
HCA
$107B
$73K ﹤0.01%
+834
New +$67K
2017 Q4
0 quarters
MTB icon
369
M&T Bank
MTB
$31.6B
$73K ﹤0.01%
+429
New +$71.2K
2017 Q4
0 quarters
PEG icon
370
Public Service Enterprise Group
PEG
$37.9B
$73K ﹤0.01%
+1,412
New +$71.2K
2017 Q4
0 quarters
HBM.WS icon
371
DELISTED
Hudbay Warrants
HBM.WS
$72K ﹤0.01%
231,138
– –
2014 Q4
12 quarters
AVEO
372
DELISTED
AVEO Pharmaceuticals
AVEO
$70K ﹤0.01%
+2,520
New +$78.2K
2017 Q4
0 quarters
HRL icon
373
Hormel Foods
HRL
$12.5B
$69K ﹤0.01%
+1,899
New +$63.8K
2017 Q4
0 quarters
WELL icon
374
Welltower
WELL
$181B
$68K ﹤0.01%
+1,067
New +$71.6K
2017 Q4
0 quarters
CELH icon
375
Celsius Holdings
CELH
$8.33B
$67K ﹤0.01%
+38,442
New +$67.5K
2017 Q4
0 quarters

Similar funds

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo, cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.